| Product Name | MF | CAS | Details |
|---|
| H-DVSQSSISFQIEK-OH | Details |
| H-EGE-OH | Details |
| H-RPEAPPSYAEVVT-OH | Details |
| 7-Phenyl-4H,5H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one | C11H8N4O | 34102-81-3 | Details |
| N-Acetylneuraminic acid pentamer penta sodium | Details |
| N-Cyclohexylaniline | C12H17N | 1821-36-9 | Details |
| 2-{1-[(tert-Butoxy)carbonyl]-4,4-dimethylpyrrolidin-2-yl}acetic acid | C13H23NO4 | 2167516-48-3 | Details |
| Ethylene glycol bis(propionitrile) ether | C8H12N2O2 | 3386-87-6 | Details |
| 2-(Prop-2-yn-1-yl)oxolane-2-carboxylic acid | C8H10O3 | 1936666-75-9 | Details |
| (Isocyanatomethyl)cyclopropane | C5H7NO | 25694-89-7 | Details |
| (2R)-2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-isopropylpentanenitrile hydrochloride | C27H41ClN2O5 | 38176-02-2 | Details |
| Recombinant Human Secreted Frizzled Related Protein-1 | Details |
| 2-Methyl-3-(3,4-methylenediOxyphenyl)prOpanal | C11H12O3 | 1205-17-0 | Details |
| Ravagalimab | 2050816-56-1 | Details |
| 7-Cyano-7-deaza-2'-deoxyadenosine | C12H13N5O3 | 15676-19-4 | Details |
| 1-(2,4-difluorophenyl)-3-((4-methylphenyl)sulfonyl)urea | C14H12F2N2O3S | 401640-37-7 | Details |
| Goat anti Guinea Pig IgG (H + L) (HRP) | Details |
| 3-Deoxy sphingosine | C18H37NO | 126624-36-0 | Details |
| 1-Benzyl-3-bromopiperidin-2-one | C12H14BrNO | 77868-86-1 | Details |
| 2-Amino-5-methyl-3-nitrobenzoic acid | C8H8N2O4 | 5465-34-9 | Details |
| 4-(Trifluoromethyl)-1H-imidazol-2-amine hydrochloride | C4H5ClF3N3 | 1803611-83-7 | Details |
| 6-Oxo-23-norpristimerol | C29H38O5 | 118172-79-5 | Details |
| 4,4-Difluorobutan-1-amine hydrochloride | C4H10ClF2N | 811842-33-8 | Details |
| N-[2-(Piperazin-1-yl)ethyl]thiophene-2-carboxamide | C11H17N3OS | 1082576-54-2 | Details |
| 1-(2,2-Dimethoxyethyl)-2-fluorobenzene | C10H13FO2 | 1269151-82-7 | Details |
| HSP70-IN-1 | C24H28N6O2S | 1268273-90-0 | Details |
| N-(tert-Butoxycarbonyl) desethylene ciprofloxacin | C20H24FN3O5 | 105589-00-2 | Details |
| 3-(4-Fluorophenyl)-3-methylpyrrolidine | C11H14FN | 1248610-21-0 | Details |
| 5-[(4-Bromo-1H-pyrazol-1-yl)methyl]-3-methylfuran-2-carboxylic acid | C10H9BrN2O3 | 1183176-76-2 | Details |
| 2-Methyl-1,4-naphthohydroquinone | C11H10O2 | 481-85-6 | Details |
| Methyl 3-amino-4-bromo-2,6-difluorobenzoate | C8H6BrF2NO2 | 1529613-64-6 | Details |
| GRM7 antibody | Details |
| 2-[(2R,4S)-4-Methoxypyrrolidin-2-yl]-5-methyl-1,3,4-oxadiazole | C8H13N3O2 | 1932574-68-9 | Details |
| 3-Methoxybenzyl alcohol | C8H10O2 | 6971-51-3 | Details |
| HPSE Blocking Peptide | Details |
| MYBPH Blocking Peptide | Details |
| Remdesivir impurity 8 | C9H20ClNO2 | 946511-97-3 | Details |
| HSPA14 antibody | Details |
| GAD1 protein (His tag) | Details |
| Nb[n-N-butyl-N-acetyl]aminopropionic acid ethyl ester | C11H21NO3 | 52304-36-6 | Details |
| Oxanthroquinone G01 | C20H18O6 | 1616622-15-1 | Details |
| Bisdemethoxycurcumin | C19H16O4 | 52328-96-8 | Details |
| 5-(2-Chlorophenoxymethyl)-4-phenyl-4H-1,2,4-triazole-3-thiol | C15H12ClN3OS | 64910-34-5 | Details |
| 4H,5H,6H,7H,8H-Furo[3,2-c]azepin-4-one | C8H9NO2 | 61190-48-5 | Details |
| tert-Butyl N-{5-aminobicyclo[3.1.1]heptan-1-yl}carbamate | C12H22N2O2 | 1049607-15-9 | Details |
| 6-Bromo-2-naphthyl-alpha-D-mannopyranoside | C16H17BrO6 | 28541-84-6 | Details |
| N-tert-Butyl-1-formylcyclopropane-1-sulfonamide | C8H15NO3S | 1409950-09-9 | Details |
| 1,8-Octyldiisocyanate | C10H16N2O2 | 10124-86-4 | Details |
| methyl 4-bromo-2,3-difluoro-5-iodobenzoate | C8H4BrF2IO2 | 1878217-46-9 | Details |
| Glycidyl palmitate | C19H36O3 | 7501-44-2 | Details |
| Dinutuximab | 1363687-32-4 | Details |
| Batimastat | C23H31N3O4S2 | 130370-60-4 | Details |
| 5-Oxo-1-(2,2,2-trifluoroethyl)pyrrolidine-3-carboxylic acid | C7H8F3NO3 | 1016823-41-8 | Details |
| 3-[(1-Methyl-1H-imidazol-2-yl)sulfanyl]propanoic acid | C7H10N2O2S | 919467-05-3 | Details |
| N3-Methyluridine | C10H14N2O6 | 2140-69-4 | Details |
| PDCL antibody | Details |
| 2-(6-Hydroxypyridin-3-yl)isoindole-1,3-dione | C13H8N2O3 | 1854670-44-2 | Details |
| 1-[2-(2-Bromophenyl)-4-methyl-1,3-thiazol-5-yl]ethan-1-amine | C12H13BrN2S | 1249254-72-5 | Details |
| Fmoc-b-Ala-4-Cpa-OH | Details |
| 2H-[1,3]Dioxolo[4,5-c]pyridine-6-carboxylic acid | C7H5NO4 | 521278-13-7 | Details |
| MAPK14 protein (His tag) | Details |
| N-2-Phenylpyridine-2,4-diamine | C11H11N3 | 25194-51-8 | Details |
| 3-(2-Methylcyclopropyl)-1,2-oxazol-5-amine | C7H10N2O | 1152571-99-7 | Details |
| 6-(2-Phenylethoxy)pyridin-3-amine | C13H14N2O | 1039335-46-0 | Details |
| 2-(3-Methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride | C12H16ClNO3 | 1864052-34-5 | Details |
| CD18 antibody (biotin) | Details |
| (3-Methylphenyl)(phenyl)methanol | C14H14O | 21945-66-4 | Details |
| ({2-[(2-Fluorophenyl)methoxy]-3-methoxyphenyl}methyl)(methyl)amine hydrochloride | C16H18NO2F·HCl | 1049713-63-4 | Details |
| 2-Amino-2-(4-methoxyphenyl)acetic acid hydrochloride | C9H12ClNO3 | 134722-07-9 | Details |
| N-(3-Aminopropyl)-2-bromo-5-methoxybenzamide hydrochloride | C11H16BrClN2O2 | 1803586-25-5 | Details |
| 3-Ethyl-4-(hydroxymethyl)oxolan-2-ones | C7H12O3 | 408330-40-5 | Details |
| TIAM antibody | Details |
| 3-(2,5-Dimethyl-1H-pyrrol-1-yl)-4-methoxybenzoic acid | C14H15NO3 | 1274929-77-9 | Details |
| 3-Hydroxypropane-1-sulfonyl fluoride | C3H7FO3S | 1803600-26-1 | Details |
| APOA5 antibody | Details |
| H-WAIIEEFTK^-OH | Details |
| GOLGA5 Blocking Peptide | Details |
| ethyl 2-(6-methyl-1-(5-methylisoxazol-3-yl)-4-oxo-5,6,7-trihydroindol-2-yl)acetate | C17H20N2O4 | 1024392-26-4 | Details |
| 4-(5-Fluoro-1H-1,3-benzodiazol-2-yl)aniline | C13H10FN3 | 872552-44-8 | Details |
| N-(trans-3-Hydroxycotinine)-b-D-glucuronide methyl-D3 | Details |
| 1-[2-(Trifluoromethyl)benzoyl]-1,4-diazepane hydrochloride | C13H16ClF3N2O | 1593112-79-8 | Details |
| Potassium Trifluoro(2,2,2-trifluoroethyl)borate | C2HBF6K | 1510778-85-4 | Details |
| Methyl 2-[2-(dimethylamino)ethyl]pyrrolidine-1-carboxylate | 2163641-52-7 | Details |
| [5-TAMRA]/[Lys(BHQ-2)] Ubiquitin | Details |
| 3-Amino-1-(1,3-dioxaindan-5-yl)urea | C8H9N3O3 | 756791-27-2 | Details |
| 3-Cyclopropyl-2,2-difluoro-3-hydroxypropanoic acid | C6H8F2O3 | 681240-15-3 | Details |
| {1-[(1,5-Dimethyl-1H-pyrazol-4-yl)methyl]piperidin-3-yl}methanamine dihydrochloride | C12H23ClN4 | 1431963-95-9 | Details |
| 1-[2-(Methylsulfanyl)phenyl]propan-2-one | C10H12OS | 27350-24-9 | Details |
| 8-Methoxyfenoldopam | C17H18ClNO3 | 95183-48-5 | Details |
| 1,1,1-Trifluoropentan-2-one | C5H7F3O | 383-56-2 | Details |
| rac o-Methyl tolterodine fumarate | C27H37NO5 | 1240303-69-8 | Details |
| SLITRK1 antibody | Details |
| 3-[4-(Ethanesulfonyl)phenyl]propanoic acid | C11H14O4S | 1152497-21-6 | Details |
| 3-(1H-Indazol-5-ylformamido)propanoic acid | C11H11N3O3 | 1099107-57-9 | Details |
| (2,2-Dichloro-1-methylcyclopropyl)methanesulfonyl chloride | C5H7Cl3O2S | 1864014-99-2 | Details |
| 2-(Aminomethyl)-6-methylpyridin-3-ol dihydrochloride | C7H11ClN2O | 2260936-80-7 | Details |
| 5-(Aminomethyl)-4H,5H,6H,7H-pyrazolo[1,5-a]pyridine-3-carboxamide dihydrochloride | C9H15ClN4O | 1803593-49-8 | Details |
| Lactoferrin protein | Details |
| H-WYWGPSLYSI-OH | Details |
| N-(Prop-2-en-1-yl)-2,3-dihydro-1H-inden-1-amine hydrochloride | C12H16ClN | 2225146-78-9 | Details |
| Product Total： Product Page： | ||||
| 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 | ||||